An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. The software was rolled out commercially in April 2023.
Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing.
As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.
The National Science Foundation (NSF) is setting up seven new institutes for studying foundational AI. Two of the initiatives have healthcare as a prime focus.